Data / Form D filings / Adamis Pharmaceuticals Corp
Adamis Pharmaceuticals Corp: Form D filings
Adamis Pharmaceuticals Corp, a pharmaceuticals company in San Diego, CA, filed 9 Form D notices with the SEC between 2010 and 2023. The latest, on June 12, 2023, reports an offering of no set size with nothing sold yet to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11682 EL CAMINO REAL, SUITE 300, San Diego, CA, 92130
- Phone
- (858) 997-2400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 887247
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | New notice | Indefinite | $0 | 12 | May 25, 2023 | sec.gov | |
| Jul 7, 2022 | New notice | $300,000 | $300,000 | 1 | Jul 5, 2022 | sec.gov | |
| Jun 30, 2020 | New notice | $590,000 | $590,000 | 1 | Jun 12, 2020 | sec.gov | |
| Mar 6, 2020 | New notice | $6,090,000 | $6,090,000 | 2 | Feb 21, 2020 | sec.gov | |
| Jul 11, 2013 | New notice | $6,502,158 | $6,502,158 | 11 | Jun 26, 2013 | sec.gov | |
| Apr 24, 2013 | New notice | $575,000 | $575,000 | 2 | Apr 5, 2013 | sec.gov | |
| Jul 9, 2012 | New notice | $1,000,000 | $1,000,000 | 2 | Jun 11, 2012 | sec.gov | |
| Apr 6, 2012 | New notice | $3,299,920 | $3,299,920 | 2 | Jun 30, 2011 | sec.gov | |
| Nov 23, 2010 | New notice | $5,000,000 | $0 | $5,000,000 | 1 | Nov 10, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Meera J. Desai | Director | |
| Howard C. Birndorf | Director | |
| Ebrahim J. Versi | Executive Officer, Director | |
| Vickie S. Reed | Director | |
| David J. Marguglio | Executive Officer | |
| Jannine S. Versi | Director | |
| David C. Benedicto | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 12, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Adamis Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.